Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.

摘要

Current users, especially new users of FQs, are at a higher risk of developing PN. Despite the increase in the use of FQs, clinicians should weigh the benefits against the risk of adverse events when prescribing these drugs to their patients.